1995
DOI: 10.1002/ijc.2910630313
|View full text |Cite
|
Sign up to set email alerts
|

Expression of MAGE genes in primary and metastatic cutaneous melanoma

Abstract: Human genes MAGE-1 and MAGE-3 code for antigens that are recognized on melanoma cells by autologous cytolytic T lymphocytes. These antigens may constitute useful targets for specific anti-tumor immunization of cancer patients, since genes MAGE-1 and MAGE-3 are expressed in a number of tumors of different histological types, but are not expressed in normal adult tissues other than testis. This also applies to genes MAGE-2 and MAGE-4, which are closely related to MAGE-1 and MAGE-3. We have analyzed the expressio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
156
1
1

Year Published

1996
1996
2005
2005

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 258 publications
(173 citation statements)
references
References 19 publications
15
156
1
1
Order By: Relevance
“…CTA belonging to the MAGE, GAGE and SSX gene families were highly expressed in MM cells analysed (Table 1). This pattern of CTA expression in MM is consistent with the elevated frequency of MAGE family gene expression reported in metastatic melanomas (Brasseur et al, 1995); indeed, five out of six MM cells examined expressed MAGE-1 and/or -2, and/or -3 genes (Table 1). Noteworthy, MAGE-3 was highly expressed by MM cells; this finding suggests that MAGE-3, an extensively utilised therapeutic target for cancer immunotherapy (Marchand et al, 1999;Nishiyama et al, 2001), represents a promising candidate for CTAbased immunotherapy in the majority of MM patients.…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…CTA belonging to the MAGE, GAGE and SSX gene families were highly expressed in MM cells analysed (Table 1). This pattern of CTA expression in MM is consistent with the elevated frequency of MAGE family gene expression reported in metastatic melanomas (Brasseur et al, 1995); indeed, five out of six MM cells examined expressed MAGE-1 and/or -2, and/or -3 genes (Table 1). Noteworthy, MAGE-3 was highly expressed by MM cells; this finding suggests that MAGE-3, an extensively utilised therapeutic target for cancer immunotherapy (Marchand et al, 1999;Nishiyama et al, 2001), represents a promising candidate for CTAbased immunotherapy in the majority of MM patients.…”
Section: Discussionsupporting
confidence: 85%
“…Oligonucleotide primer sequences and gene-specific PCR amplification programs utilised have been defined for MAGE-1, -2, -3, -4 (Brasseur et al, 1995), NY-ESO-1 (Jäger et al, 1998), GAGE 1-2 (Van den Eynde et al, 1995), GAGE 1-6 (Van den Eynde et al, 1995), SSX 1-5 (dos Santos et al, 2000), SSX-2 (Sahin et al, 2000), RAGE-1 (Neumann et al, 1998), tyrosinase and Melan-A/MART-1 (van Elsas et al, 1996). The integrity of each RNA and oligo-dT-synthesised cDNA sample was confirmed by the amplification of the b-actin housekeeping gene (Coral et al, 1999).…”
Section: Monoclonal Antibodies Antisera Reagents and Biochemical Asmentioning
confidence: 99%
“…47 On an mRNA level, correlation between CT antigen expression and tumor stage has been reported in several tumors such as renal cell carcinoma, 48 bladder 49 and esophageal carcinoma, 50 and melanoma. 51 This association has not been demonstrated in others: head and neck carcinoma, 52 seminoma 18 stomach, 53 or colon. 54 In our present analysis, we did not find any correlation between tumor stage and CT antigen expression, although we documented a relationship between grade and CT antigen expression, particularly for 57B and CT7-33.…”
Section: Discussionmentioning
confidence: 90%
“…In this regard, residence on the X chromosome with a single active copy probably renders these genes more highly susceptible to derepression events. The finding that some CT antigens (e.g., MAGE and BAGE) are more frequently expressed in metastatic melanomas than primary lesions (9,30) suggests that such derepression may be a later event in tumor progression.…”
Section: Discussionmentioning
confidence: 99%